We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

251 hedge funds and large institutions have $1.5B invested in BioTelemetry, Inc. in 2019 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 111 increasing their positions, 71 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 111 | Existing positions reduced: 71

19% less funds holding

Funds holding: 311251 (-60)

23% less capital invested

Capital invested by funds: $1.94B → $1.5B (-$444M)

48% less call options, than puts

Call options by funds: $12.1M | Put options by funds: $23.3M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

61% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 90

Holders
251
Holders Change
-60
Holders Change %
-19.29%
% of All Funds
5.45%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
35
Increased
111
Reduced
71
Closed
90
Calls
$12.1M
Puts
$23.3M
Net Calls
-$11.2M
Net Calls Change
-$7.01M

BEAT Hedge Fund Activity: Q2 2019 in Review

251 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2019, worth a combined $1.5B — down 23% from $1.94B a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of BEAT and 35 opened new positions — a net loss of 55 holders — while 71 trimmed existing stakes and 111 added.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $105M. The largest seller was Macquarie Group, exiting entirely with an estimated $47.7M sold.

  • 251 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2019, down from 311 in Q1 2019.
  • Funds reported $1.5B of BioTelemetry, Inc. stock for Q2 2019, down 23% quarter-over-quarter.
  • 35 funds opened new BioTelemetry, Inc. positions in Q2 2019 and 90 closed out, a net change of -55 holders.
  • The largest BioTelemetry, Inc. buyer in Q2 2019 was ArrowMark Colorado Holdings, an estimated $105M added.
  • The largest BioTelemetry, Inc. seller in Q2 2019 was Macquarie Group, an estimated $47.7M sold.

Based on aggregated 13F filings for Q2 2019.